Vertex achieved its highest level of activity for fiscal 2024 in the current quarter, reporting an adjusted EBITDA (1) of $11.9 million, surpassing the previous company record by $1.0 million. This ...

The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...

CREC will receive delivery of Trinasolar’s Vertex N 720W Series of n-type tunnel oxide passivated contact (TOPCon) modules.

Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ETCompany ParticipantsJoe Crivelli - Vice President, ...

Vertex will host a conference call at 8:30 a.m. Eastern Time today, November 6, 2024, to discuss its third quarter 2024 ...

With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...

Vertex Pharmaceuticals Inc (VRTX) reports a 12% revenue increase and raises full-year guidance, while navigating challenges ...

Operator Good day, and welcome to the Vertex Pharmaceuticals third quarter 2024 earnings call. All participants will be in a ...

Google Cloud AI to enhance Honeywell’s product offerings and help upskill the industrial workforce New solutions will connect to enterprise-wide industrial data from Honeywell Forge, a leading IoT ...

At the heart of SurgeGraph Vertex is the Humanizer, a technology that automatically refines and delivers AI-generated content ...

7. Navitas Semiconductor(NASDAQ: NVTS) is transforming power delivery with its efficient gallium nitride charging technology.

Services and features affected included: Cloud Build, Cloud Developer Tools, Cloud Machine Learning, Google Cloud Dataflow, Google Cloud Dataproc, Google Cloud Pub/Sub, Google Compute Engine, Google ...